UPDATE 1-Integra LifeSciences Q1 tops estimates, backs ’10 view

* Adjusted Q1 EPS $0.63 vs est $0.57

* Q4 rev $172.7 mln vs est $171.1 mln

* Still sees ’10 rev of $715 mln-$735 mln

* Still sees ’10 adjusted EPS of $2.60-$2.75

May 3 (BestGrowthStock) – Medical device maker Integra LifeSciences
Holdings Corp (IART.O: ) posted a quarterly profit that topped
market expectations, helped by strong growth in its orthopedics
and neurosciences segments, and backed its 2010 earnings and
revenue view.

First-quarter net income was $15.2 million, or 50 cents per
share, compared with $9.6 million, or 32 cents per share, in
the year-ago period.

Adjusted net income was 63 cents a share. Revenue rose 7
percent to $172.7 million.

Analysts were expecting it to earn 57 cents a share, on
revenue of $171.1 million, according to Thomson Reuters
I/B/E/S.

Orthopedics sales rose 9 percent to $70.2 million and
neurosciences sales increased 8 percent to $64.8 million.

Shares of the company closed at $45.43 Friday on Nasdaq.

Stock Market Today

(Reporting by Esha Dey in Bangalore; Editing by Ratul Ray
Chaudhuri)

UPDATE 1-Integra LifeSciences Q1 tops estimates, backs ’10 view